{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:55:32Z","timestamp":1794646532002,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["2-2011-597"],"award-info":[{"award-number":["2-2011-597"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["2-2011-597"],"award-info":[{"award-number":["2-2011-597"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01-EY022330"],"award-info":[{"award-number":["R01-EY022330"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxnard Foundation","id":[{"id":"https:\/\/ror.org\/008p88242","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Gerwin Fellowship"},{"DOI":"10.13039\/100002089","name":"Fight for Sight","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Unrestricted Grant"],"award-info":[{"award-number":["Unrestricted Grant"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007737","name":"St. Jude Children's Research Hospital","doi-asserted-by":"publisher","award":["Chair Endowment"],"award-info":[{"award-number":["Chair Endowment"]}],"id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]},{"name":"West Cancer Center","id":[{"id":"https:\/\/ror.org\/01jkda844","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3418-y","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T08:32:08Z","timestamp":1497947528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":241,"title":["Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Anderson H.","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary K.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin B.","family":"Lendermon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajini","family":"Bheemreddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jena J.","family":"Steinle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Morales-Tirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"issue":"1","key":"3418_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/bjo.2008.138750","volume":"93","author":"E Broaddus","year":"2009","unstructured":"Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975-2004. Br J Ophthalmol. 2009;93(1):21\u20133. PubMed PMID: 18621794","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3418_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ajmg.c.30024","volume":"129C","author":"DR Lohmann","year":"2004","unstructured":"Lohmann DR, Gallie BL. Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C: Semin Med Genet. 2004;129C(1):23\u20138. PubMed PMID: 15264269","journal-title":"Am J Med Genet C: Semin Med Genet"},{"issue":"6","key":"3418_CR3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3928\/0191-3913-19851101-11","volume":"22","author":"DH Abramson","year":"1985","unstructured":"Abramson DH, Ellsworth RM, Grumbach N, Kitchin FD. Retinoblastoma: survival, age at detection and comparison 1914-1958, 1958-1983. J Pediatr Ophthalmol Strabismus. 1985;22(6):246\u201350. PubMed PMID: 4078667","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"4","key":"3418_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3928\/0191-3913-19860701-06","volume":"23","author":"DH Abramson","year":"1986","unstructured":"Abramson DH, Ellsworth RM, Grumbach N, Sturgis-Buckhout L, Haik BG. Retinoblastoma: correlation between age at diagnosis and survival. J Pediatr Ophthalmol Strabismus. 1986;23(4):174\u20137. PubMed PMID: 3746592","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"3","key":"3418_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/13816818909009874","volume":"10","author":"CM Erwenne","year":"1989","unstructured":"Erwenne CM, Franco EL. Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic paediatrics and genetics. 1989;10(3):179\u201384. PubMed PMID: 2587030","journal-title":"Ophthalmic paediatrics and genetics"},{"issue":"8","key":"3418_CR6","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0161-6420(86)33629-7","volume":"93","author":"M Rubenfeld","year":"1986","unstructured":"Rubenfeld M, Abramson DH, Ellsworth RM, Kitchin FD. Unilateral vs. bilateral retinoblastoma. Correlations between age at diagnosis and stage of ocular disease. Ophthalmology. 1986;93(8):1016\u20139. PubMed PMID: 3763146","journal-title":"Ophthalmology"},{"issue":"3","key":"3418_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0165-4608(82)90026-7","volume":"5","author":"JL Bader","year":"1982","unstructured":"Bader JL, Meadows AT, Zimmerman LE, Rorke LB, Voute PA, Champion LA, et al. Bilateral retinoblastoma with ectopic intracranial retinoblastoma: trilateral retinoblastoma. Cancer Genet Cytogenet. 1982;5(3):203\u201313. PubMed PMID: 7066879","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"3418_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0161-6420(91)32325-X","volume":"98","author":"EP Messmer","year":"1991","unstructured":"Messmer EP, Heinrich T, Hopping W, de Sutter E, Havers W, Sauerwein W. Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 1991;98(2):136\u201341. PubMed PMID: 2008269","journal-title":"Ophthalmology"},{"issue":"9","key":"3418_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/bjo.77.9.544","volume":"77","author":"CL Shields","year":"1993","unstructured":"Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77(9):544\u20138. PubMed PMID: 8218048. Pubmed Central PMCID: 513947","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"3418_CR10","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.5858\/133.8.1199","volume":"133","author":"X Sastre","year":"2009","unstructured":"Sastre X, Chantada GL, Doz F, Wilson MW, de Davila MT, Rodriguez-Galindo C, et al. Proceedings of the consensus meetings from the International retinoblastoma staging working group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Archives of pathology & laboratory medicine. 2009;133(8):1199\u2013202. PubMed PMID: 19653709","journal-title":"Archives of pathology & laboratory medicine"},{"issue":"2","key":"3418_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","volume":"41","author":"T Klein","year":"2011","unstructured":"Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids. 2011;41(2):271\u201390. PubMed PMID: 20640864. Pubmed Central PMCID: 3102199","journal-title":"Amino Acids"},{"issue":"3","key":"3418_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221\u201333. PubMed PMID: 17318226. Pubmed Central PMCID: 2760082","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3418_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1385\/MB:22:1:051","volume":"22","author":"CM Overall","year":"2002","unstructured":"Overall CM. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol. 2002;22(1):51\u201386. PubMed PMID: 12353914","journal-title":"Mol Biotechnol"},{"issue":"1","key":"3418_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s13277-014-2747-6","volume":"36","author":"E Wieczorek","year":"2015","unstructured":"Wieczorek E, Jablonska E, Wasowicz W, Reszka E. Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36(1):163\u201375. PubMed PMID: 25352026. Pubmed Central PMCID: 4315474","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"9","key":"3418_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S1359-6446(01)01752-4","volume":"6","author":"HD Foda","year":"2001","unstructured":"Foda HD, Zucker S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today. 2001;6(9):478\u201382. PubMed PMID: 11344033","journal-title":"Drug Discov Today"},{"issue":"6","key":"3418_CR16","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0002-9440(10)64660-3","volume":"158","author":"S Zucker","year":"2001","unstructured":"Zucker S, Hymowitz M, Rollo EE, Mann R, Conner CE, Cao J, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol. 2001;158(6):1921\u20138. PubMed PMID: 11395366. Pubmed Central PMCID: 1891983","journal-title":"Am J Pathol"},{"key":"3418_CR17","doi-asserted-by":"publisher","first-page":"191670","DOI":"10.1155\/2011\/191670","volume":"2011","author":"L Devy","year":"2011","unstructured":"Devy L, Dransfield DT. New strategies for the Next generation of matrix-metalloproteinase inhibitors: selectively targeting membrane-anchored MMPs with therapeutic antibodies. Biochem Res Int. 2011;2011:191670. PubMed PMID: 21152183. Pubmed Central PMCID: 2989751","journal-title":"Biochem Res Int"},{"key":"3418_CR18","unstructured":"GileadSciences. [05.26.2016]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01803282?term=NCT01803282 ."},{"issue":"5","key":"3418_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127063","volume":"10","author":"DC Marshall","year":"2015","unstructured":"Marshall DC, Lyman SK, McCauley S, Kovalenko M, Spangler R, Liu C, et al. Selective allosteric inhibition of MMP9 is efficacious in preclinical models of ulcerative colitis and colorectal cancer. PLoS One. 2015;10(5):e0127063. PubMed PMID: 25961845. Pubmed Central PMCID: 4427291","journal-title":"PLoS One"},{"issue":"6","key":"3418_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/MPH.0b013e3180683bf1","volume":"29","author":"M Adithi","year":"2007","unstructured":"Adithi M, Nalini V, Kandalam M, Krishnakumar S. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma. J Pediatr Hematol Oncol. 2007;29(6):399\u2013405. PubMed PMID: 17551402","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"3418_CR21","first-page":"489","volume":"4","author":"H Long","year":"2011","unstructured":"Long H, Zhou B, Jiang FG. Expression of MMP-2 and MMP-9 in retinoblastoma and their significance. International journal of ophthalmology. 2011;4(5):489\u201391. PubMed PMID: 22553708. Pubmed Central PMCID: 3340721","journal-title":"International journal of ophthalmology"},{"issue":"2","key":"3418_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/jnci\/53.2.347","volume":"53","author":"TW Reid","year":"1974","unstructured":"Reid TW, Albert DM, Rabson AS, Russell P, Craft J, Chu EW, et al. Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst. 1974;53(2):347\u201360. PubMed PMID: 4135597","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3418_CR23","first-page":"1003","volume":"37","author":"RC McFall","year":"1977","unstructured":"McFall RC, Sery TW, Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 1977;37(4):1003\u201310. PubMed PMID: 844036","journal-title":"Cancer Res"},{"key":"3418_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnagi.2016.00093","volume":"8","author":"SR Chintalapudi","year":"2016","unstructured":"Chintalapudi SR, Djenderedjian L, Stiemke AB, Steinle JJ, Jablonski MM, Morales-Tirado VM. Isolation and Molecular profiling of primary mouse retinal ganglion cells: comparison of phenotypes from healthy and glaucomatous retinas. Front Aging Neurosci. 2016;8:93. PubMed PMID: 27242509. Pubmed Central PMCID: 4870266","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"3418_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/febs.13620","volume":"283","author":"SR Chintalapudi","year":"2016","unstructured":"Chintalapudi SR, Morales-Tirado VM, Williams RW, Jablonski MM. Multipronged approach to identify and validate a novel upstream regulator of Sncg in mouse retinal ganglion cells. FEBS J. 2016;283(4):678\u201393. PubMed PMID: 26663874","journal-title":"FEBS J"},{"issue":"2","key":"3418_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.4049\/jimmunol.173.2.726","volume":"173","author":"V Morales-Tirado","year":"2004","unstructured":"Morales-Tirado V, Johannson S, Hanson E, Howell A, Zhang J, Siminovitch KA, et al. Cutting edge: selective requirement for the Wiskott-Aldrich syndrome protein in cytokine, but not chemokine, secretion by CD4+ T cells. J Immunol. 2004;173(2):726\u201330. PubMed PMID: 15240657","journal-title":"J Immunol"},{"key":"3418_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13098-015-0068-6","volume":"7","author":"BT Gao","year":"2015","unstructured":"Gao BT, Lee RP, Jiang Y, Steinle JJ, Morales-Tirado VM. Pioglitazone alters monocyte populations and stimulates recent thymic emigrants in the BBDZR\/Wor type 2 diabetes rat model. Diabetology & metabolic syndrome. 2015;7:72. PubMed PMID: 26336514. Pubmed Central PMCID: 4557231","journal-title":"Diabetology & metabolic syndrome"},{"issue":"1","key":"3418_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1167\/iovs.14-15550","volume":"56","author":"S Thakran","year":"2014","unstructured":"Thakran S, Zhang Q, Morales-Tirado V, Steinle JJ. Pioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions. Invest Ophthalmol Vis Sci. 2014;56(1):177\u201384. PubMed PMID: 25525174. Pubmed Central PMCID: 4294286","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"3418_CR29","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1167\/iovs.13-12326","volume":"54","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Jiang Y, Toutounchian J, Wilson MW, Morales-Tirado V, Miller DD, et al. Novel quinic acid derivative KZ-41 prevents retinal endothelial cell apoptosis without inhibiting retinoblastoma cell death through p38 signaling. Invest Ophthalmol Vis Sci. 2013;54(9):5937\u201343. PubMed PMID: 23942968. Pubmed Central PMCID: 3762329","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"3418_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrd4390","volume":"13","author":"RE Vandenbroucke","year":"2014","unstructured":"Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov. 2014;13(12):904\u201327. PubMed PMID: 25376097","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"3418_CR31","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9440(10)64653-6","volume":"157","author":"P Chevez-Barrios","year":"2000","unstructured":"Chevez-Barrios P, Hurwitz MY, Louie K, Marcus KT, Holcombe VN, Schafer P, et al. Metastatic and nonmetastatic models of retinoblastoma. Am J Pathol. 2000;157(4):1405\u201312. PubMed PMID: 11021842. Pubmed Central PMCID: 1850157","journal-title":"Am J Pathol"},{"issue":"2","key":"3418_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1101\/gad.949802","volume":"16","author":"B Ren","year":"2002","unstructured":"Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)\/M checkpoints. Genes Dev. 2002;16(2):245\u201356. PubMed PMID: 11799067. Pubmed Central PMCID: 155321","journal-title":"Genes Dev"},{"key":"3418_CR33","doi-asserted-by":"crossref","unstructured":"Albert DM, Tapper D, Robinson NL, Felman R. Retinoblastoma and angiogenesis activity. Retina. 1984 Summer-Fall;4(3):189\u201394. PubMed PMID: 6208587.","DOI":"10.1097\/00006982-198400430-00011"},{"issue":"9","key":"3418_CR34","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1167\/iovs.06-1234","volume":"48","author":"M Hollborn","year":"2007","unstructured":"Hollborn M, Stathopoulos C, Steffen A, Wiedemann P, Kohen L, Bringmann A. Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest Ophthalmol Vis Sci. 2007;48(9):4360\u20137. PubMed PMID: 17724228","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5422","key":"3418_CR35","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","volume":"284","author":"J Holash","year":"1999","unstructured":"Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 1999;284(5422):1994\u20138. PubMed PMID: 10373119","journal-title":"Science"},{"key":"3418_CR36","doi-asserted-by":"publisher","first-page":"521754","DOI":"10.1155\/2014\/521754","volume":"2014","author":"J Krstic","year":"2014","unstructured":"Krstic J, Santibanez JF. Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. TheScientificWorldJOURNAL. 2014;2014:521754. PubMed PMID: 24578639. Pubmed Central PMCID: 3918721","journal-title":"TheScientificWorldJOURNAL"},{"issue":"7","key":"3418_CR37","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/01.STR.0000170712.46106.2e","volume":"36","author":"Y Zhu","year":"2005","unstructured":"Zhu Y, Lee C, Shen F, Du R, Young WL, Yang GY. Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain. Stroke. 2005;36(7):1533\u20137. PubMed PMID: 15947259","journal-title":"Stroke"},{"issue":"3","key":"3418_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0002-9440(10)62308-5","volume":"166","author":"P Guo","year":"2005","unstructured":"Guo P, Imanishi Y, Cackowski FC, Jarzynka MJ, Tao HQ, Nishikawa R, et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol. 2005;166(3):877\u201390. PubMed PMID: 15743799. Pubmed Central PMCID: 1602359","journal-title":"Am J Pathol"},{"issue":"6","key":"3418_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm0603-653","volume":"9","author":"P Carmeliet","year":"2003","unstructured":"Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9(6):653\u201360. PubMed PMID: 12778163","journal-title":"Nat Med"},{"issue":"6958","key":"3418_CR40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425(6958):577\u201384. PubMed PMID: 14534577","journal-title":"Nature"},{"issue":"6 Pt 2","key":"3418_CR41","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1083\/jcb.127.6.2021","volume":"127","author":"PJ Miettinen","year":"1994","unstructured":"Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol. 1994;127(6 Pt 2):2021\u201336. PubMed PMID: 7806579. Pubmed Central PMCID: 2120317.","journal-title":"J Cell Biol"},{"issue":"Pt 24","key":"3418_CR42","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1242\/jcs.112.24.4557","volume":"112","author":"E Piek","year":"1999","unstructured":"Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P. TGF-(beta) type I receptor\/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci. 1999;112(Pt 24):4557\u201368. PubMed PMID: 10574705","journal-title":"J Cell Sci"},{"issue":"5","key":"3418_CR43","first-page":"1375","volume":"25","author":"ES Kim","year":"2004","unstructured":"Kim ES, Kim MS, Moon A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol. 2004;25(5):1375\u201382. PubMed PMID: 15492828","journal-title":"Int J Oncol"},{"issue":"5","key":"3418_CR44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2015.01.043","volume":"160","author":"N Oshimori","year":"2015","unstructured":"Oshimori N, Oristian D, Fuchs E. TGF-beta promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell. 2015;160(5):963\u201376. PubMed PMID: 25723170. Pubmed Central PMCID: 4509607","journal-title":"Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3418-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-017-3418-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3418-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T17:36:12Z","timestamp":1719250572000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3418-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3418"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3418-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]},"assertion":[{"value":"13 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"434"}}